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dkfz.de (K. Gülow).NF-jB is a crucial transcription factor regulating apoptosis sensitivity and resistance. It has been
shown that inhibition of NF-jB in T lymphocytes leads to sensitization towards apoptosis. The
underlying molecular mechanism is not entirely understood. Therefore, we investigated T cell
receptor (TCR) stimulated apoptosis in T cells in which NF-jB activity is blocked by an inhibitor
or IjBa overexpression. We show that enhanced apoptosis upon TCR stimulation is caspase- and
JNK-dependent, but independent of the CD95/CD95L system. Generation of reactive oxygen species
(ROS) induced sustained JNK phosphorylation by inactivation of MAP kinase phosphatase 7
(MKP7). Sustained JNK activation causes upregulation of the pro-apototic protein BIM. Thus, inhibi-
tion of NF-jB causes a switch from classical activation-induced cell death (AICD) to CD95L-
independent apoptosis.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Control of T lymphocyte function and proliferation is crucial for
the homeostatic balance of the immune system. Disturbance of cel-
lular homeostasis, either by uncontrolled proliferation or excessive
loss of lymphocytes, has substantial effects in disease states such
as cancer, autoimmunity and AIDS. One process by which the im-
mune system is kept in balance is TCR-mediated apoptosis of
pre-activated lymphocytes (AICD) [1]. Triggering of TCR induces
expression of the CD95L which is secreted and binds to CD95, thus
inducing a CD95L-dependent apoptosis [1,2]. An important mole-
cule involved in regulation of lymphocyte fate and execution of im-
mune functions is the transcription factor nuclear factor kappa B
(NF-jB). NF-jB determines decisions of cells between life and
death by promoting survival through induction of NF-jB target
genes. The products of these target genes regulate apoptosis in
both normal and malignant cells [3]. The NF-jB pathway is acti-
vated by the TCR stimulation which induces expression of anti-
apoptotic NF-jB target genes. These genes include c-FLIP, Bcl-2,
Bcl-XL, and IAP/XIAP [4]. In conclusion, inhibition of the NF-jB
pathway and simultaneous TCR stimulation increase cell death in
peripheral T cells of humans and mice [5,6]. Therefore, targetingchemical Societies. Published by E
eßling), b.linke@dkfz.de (B.
suess@dkfz.de (D. Süss), p.
z-heidelberg.de, k.guelow@the NF-jB pathway might yield new therapeutic strategies for clin-
ical treatment of haematopoietic malignancies. Recently, we have
shown that inhibition of the NF-jB pathway induces cell death
in cells from cutaneous T cell lymphoma (CTCL) patients by dereg-
ulation of iron homeostasis [7].
It was shown that NF-jB is involved in the regulation of reactive
oxygen species (ROS) by mediating the upregulation of anti-oxida-
tive proteins including manganese superoxide dismutase (MnSOD,
SOD2) and ferritin heavy chain (FHC) in ﬁbroblasts upon TNFa
stimulation [8,9]. P65/ ﬁbroblasts showed increased ROS levels
leading to increased cell death upon TNFa stimulation [8,9]. Anti-
oxidant agents reduced TNFa-mediated cell death in mouse
embryonic ﬁbroblasts.
We have shown that TCR stimulation induces an oxidative sig-
nal crucial for induction of CD95/CD95L dependent AICD [10,11].
NF-jB regulates the expression of several anti-oxidative proteins
[8,9]. Therefore, we were interested in the mechanisms that are in-
volved in TCR-induced apoptosis in T cells with impaired NF-jB
activation.
Here we show that inhibition of the NF-jB pathway by a chem-
ical compound or overexpression of IjBa in the Jurkat T cell line
J16-145 (named Jurkat-IjBa) strongly increased apoptosis upon
TCR or PMA/ionomycin stimulation. Cell death was independent
of the CD95- (Fas, APO-1)/CD95L system but caspase-dependent.
Interestingly, we observed that apoptosis induction of Jurkat-IjBa
cells requires ROS generation. Investigating MAPK signaling, we
observed a ROS-dependent activation of the pro-apoptotic JNK
pathway. Further, siRNA-mediated knock-down of JNK abrogatedlsevier B.V. All rights reserved.
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tial for induction of cell death. Sustained JNK activation was caused
by ROS-inactivated MAPK phosphatase 7 (MKP7). We show that
overexpression of MKP7 blocked apoptosis induction. In summary,
this is the ﬁrst evidence that inhibition of NF-jB causes a shift from
classical CD95L-dependent TCR-induced AICD towards a CD95-
independent apoptosis.
2. Materials and methods
2.1. Chemicals and antibodies
N-Acetyl-L-cysteine (NAC) was purchased from Sigma–Aldrich.
Pan-caspase inhibitor zVAD was obtained from R&D Systems.
Dichlorodihydroﬂuorescein-diacetate (H2DCFDA) was obtained
from Molecular Probes. The neutralizing anti-CD95L antibody
NOK1 was obtained from BD Pharmingen. AnnexinV-FITC antibody
was obtained from Immunotools. AnnexinV-APC antibody and 7-
amino-actinomycin were obtained from BD Bioscience Pharmin-
gen. HA-tagged JNK was kindly provided by Peter Angel, DKFZ,
Heidelberg. Dimethylfumarate and monomethylfumarate were
purchased by Sigma–Aldrich. Antibodies are described in Supple-
mentary materials and methods.
2.2. Cell culture
Jurkat J16-145 cells [11] were cultured in Roswell Park
Memorial Institute (RPMI) medium supplemented with 10% FCS
and 1 mM L-glutamine.
2.3. Isolation of human lymphocytes
Human peripheral T cells were puriﬁed as described previously
[7]. For activation, resting T cells were cultured at a concentration
of 2  106 cells/ml with 1 lg/ml phytohemagglutinin for 16 h.
Next, T cells were cultured in RPMI 1640 supplemented with 10%
FCS and 25 U/ml interleukin 2 for 6 days. All experiments
were performed with T cells isolated from at least three different
donors.
2.4. Western blot analysis
1  106 J16-145 cells were lysed for 10 min in ice-cold RIPA ly-
sis buffer (50 mM Tris–HCl, pH 8.0, 120 mM NaCl, 1% NP-40, 0.5%
Na-Desoxycholat, 0.1% SDS, 2 mM EDTA, 25 mM NaF, 0.2 mM
NaVO4, 1 mM DTT, and complete protease inhibitor cocktail from
Roche). Proteins were separated by SDS–PAGE and blotted onto
nitrocellulose membrane (Amersham Biosciences, Little Chalfon,
UK).
2.5. Phosphatase assays
To obtain phosphorylated HA-tagged JNK, HA-JNK plasmid was
transiently transfected into Jurkat J16-145 cells. After 24 h, cells
were stimulated with 10 ng/ml PMA and 10 lM ionomycin for
1 h and lysed with RIPA buffer without DTT. Phosphorylated HA-
JNK was immunoprecipitated with Protein A beads and p-HA-JNK
was eluted with elution buffer. Meanwhile, Jurkat-IjBa cells were
either left untreated or pre-incubated with 20 mM N-acetyl cys-
teine for 30 min. Then, cells were stimulated with 10 ng/ml PMA
and 10 lM ionomycin for 4 h. The cells were lysed in ice-cold RIPA
buffer without phosphatase inhibitors. The lysate was depleted of
JNK1 and JNK2 by speciﬁc antibodies and it was incubated with
p-HA-JNK for 0, 5, 15, and 30 min at 37 C. Proteins were blotted
and analyzed by phospho-JNK antibodies.2.6. ROS assays
ROS levels were assayed as described recently [12]. Cells were
stained with the oxidation-sensitive dye H2DCFDA (5 lM) for
30 min. Then, the cells were treated with 10 ng PMA or plate-
bound anti-CD3 for 1 h. Treatment was terminated by addition of
ice-cold PBS and ROS generation was determined by ﬂow cytome-
try. The increase in ﬂuorescence of treated vs. untreated samples is
shown (increase in MFI (%) = [(MFIstimulated MFIunstimulated)/
MFIunstimulated]  100).
2.7. siRNA transfection and knock-down
J16-145 cells were transfected by lipofection (HiPerfect; Qia-
gen) with Allstars Negative Control siRNA (Qiagen), siRNA oligonu-
cleotides speciﬁc for ERK2 (Qiagen), JNK1 (MAPK8, SI00300783,
Qiagen), JNK2 (MAPK9, SI02222913, Qiagen). 1  105 Jurkat J16-
145 cells in 90 ll FCS free media were incubated with 7.5 ll of
HiPerfect together with indicated amounts of siRNA oligonucleo-
tides according to the manufacturer’s instructions. After 6 h cells
were resuspended in 500 ll FCS containing media. For siRNA trans-
fection of MKP and BIM the Amaxa protocol for Jurkat cells was
used. BIM1 siRNA: 50-ggaucgcccaagaguugcggctt-30. BIM2 siRNA
50-ggccuauucucagaggauuautt-30. MKP7 (DUSP16, SI85692529, Qia-
gen). MKP7 (DUSP16, #4390824, Ambion). MKP1 (DUSP1,
SI00374801, Qiagen). MKP3 (DUSP6, SI0030324, Qiagen).
2.8. Cell death assays
For cell death induction, Jurkat cells were stimulated with
30 lg/ml plate-bound anti-CD3 and apoptosis or with 10 ng/ml
PMA and 10 lM ionomycin for the indicated time points. Cell death
was assessed by forward-to-side-scatter (FSC/SSC) proﬁle [13].
Speciﬁc cell death was calculated by using the following equation:
speciﬁc cell death (%) = (% experimental cell death  % spontane-
ous cell death)/(100%  % spontaneous cell death)  100.
3. Results
3.1. Inhibition of the NF-jB pathway induces enhanced AICD
To investigate the role of the NF-jB pathway in TCR-mediated
apoptosis, we incubated primary pre-activated T cells and J16-
145 T cells with dimethylfumarate (DMF) – an NF-jB inhibitor
(Supplementary Fig. 1A) [14]. Treatment with DMF caused an in-
crease in apoptosis in primary T cells as well as in J16-145 cells
(Fig. 1A and B) conﬁrming previous data showing enhanced T cell
death upon inhibition of NF-jB [5,6]. As expected, apoptosis in un-
treated cells was dependent on caspases and CD95L (Fig. 1A and B)
[15]. Interestingly, we observed that cell death upon DMF treat-
ment was dependent on caspases, however, independent of
CD95L. This indicates that the mechanism of TCR-induced cell
death after inhibition of the NF-jB pathway is distinct from the
pathway with intact NF-jB signaling. To further explore the molec-
ular mechanism of this increased cell death, we established Jurkat
J16-145 cells stably overexpressing IjBa (Jurkat-IjBa cells)
(Fig. 1C). The capability of Jurkat-IjBa cells to activate the NF-jB
pathway was strongly impaired (Fig. 1D). Next, we analyzed
whether apoptosis levels were altered in Jurkat-IjBa cells com-
pared to vector control cells upon TCR or PMA/ionomycin stimula-
tion. Indeed, inhibition of NF-jB in Jurkat cells resulted in a
strongly enhanced cell death (Fig. 1E and F). This cell death was
apoptotic as revealed by DNA fragmentation (Supplementary
Fig. 1B) and Annexin-V and 7-AAD staining in DMF treated cells
(Supplementary Fig. 1C and D). In conclusion, apoptosis induced
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Fig. 1. Inhibition of the NF-jB pathway enhances TCR-induced apoptosis. (A) Pre-activated T cells (day 6) were either left untreated or treated with 10 lg/ml DMF. Cells were
stimulated with anti-CD3 and apoptosis was determined at 48 h of culture. Where indicated T cells were pre-incubated with 20 lM zVAD or 5 ng/ml with NOK1. (B) Same as
in (A), but Jurkat J16-145 cells were used. (C) Stable overexpression of IjBa and of Flag-tagged IjBa was veriﬁed by Western blot. (D) Vector control and Jurkat-IjBa cells
were transfected with a plasmid encoding luciferase under transcriptional control of four NF-jB binding sites. Cells were stimulated with 10 ng/ml PMA for 8 h, then the
luciferase activity was measured. (E) Wt, vector control, and Jurkat-IjBa cells were stimulated with PMA/ionomycin for the indicated time points. Apoptosis was determined
by FACS. (F) Wt, vector control, and Jurkat-IjBa cells were stimulated with anti-CD3 antibody. Apoptosis was determined by FACS.
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cells.
3.2. Apoptosis of Jurkat-IjBa cells is CD95L-independent but ROS-
dependent
Previous work showed that ROS, as a second messenger, is re-
quired for induction of apoptosis in primary TCR stimulated T cells
[11,12]. Thus, we were interested whether ROS is involved in en-hanced apoptosis of Jurkat-IjBa cells. We observed that applica-
tion of anti-oxidants such as NAC completely abrogated cell
death in vector control and in Jurkat-IjBa cells after TCR stimula-
tion (Fig. 2A).
In T cells, ROS enhance NF-jB and AP1 activation which ﬁ-
nally induce CD95L expression and CD95-dependent apoptosis
[12]. To investigate whether the CD95/CD95L system is involved
in enhanced apoptosis after NF-jB inhibition, we co-incubated
cells with a CD95L neutralizing antibody (NOK1). As expected,
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Fig. 2. Apoptosis in Jurkat-IjBa cells is dependent on ROS. (A) Vector control and Jurkat-IjBa cells were either left untreated or pre-incubated with 20 mM NAC for 30 min.
Then, cells were stimulated with anti-CD3 antibody for the indicated time points. Apoptosis was determined by FACS. (B) Vector control cells were either left untreated or
pre-incubated with 5 ng/ml NOK1. Then, cells were stimulated with anti-CD3 antibody and apoptosis was determined. Results are representative for three individual
experiments. *P < 0.05 according to Student’s t-test. (C) Jurkat-IjBa cells were either left untreated or pre-incubated with NOK1. Then, cells were stimulated with plate-
bound anti-CD3 antibody and apoptosis was determined by FACS. Results are representative for three individual experiments. (D) Vector control and Jurkat-IjBa cells were
either left untreated or pre-incubated with 20 lM zVAD for 15 min. Then, cells were stimulated with PMA/ionomycin or with 30 lg/ml plate-bound anti-CD3 antibody for
48 h. Apoptosis was determined by FACS.
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dependent on CD95L (Fig. 2B), but apoptosis of Jurkat-IjBa cells
was independent of the CD95 system, since NOK1 did not
interfere with apoptosis induction corroborating our results in
primary T cells (Fig. 2C). In addition, we detected that celldeath in Jurkat-IjBa cells was blocked by the pan-caspase
inhibitor z-VAD (Fig. 2D). Thus, we demonstrated that
apoptosis in Jurkat-IjBa cells does not require CD95/CD95L
but is strongly dependent on ROS generation and caspase
activation.
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Since ROS play an important role in apoptosis, we askedwhether
expression of anti-oxidative enzymes is altered in Jurkat-IjBa cells.
MnSOD and FHC are typical NF-jB targets of major importance for0.00
0.50
1.00
1.50
2.00
2.50
ctr PMA/
 iono-
mycin
 α
CD3
ctr
Fo
ld
Ex
pr
es
si
on
of
M
nS
O
D
  α
CD3
PMA/
 iono-
mycin
A
0
20
40
60
80
100
ctr    PMA /
ionomycin
 α CD3
In
cr
ea
se
 in
 M
FI
 [%
]
vector
IκBα
D
C
0
20
40
60
80
100
0 10 10 10
3 4 5
Co
un
ts
         ROS
10
2
vector
      IκBαvector
ctr
PMA
αCD3
* *
Fig. 3. Jurkat-IjBa cells show reduced expression of anti-oxidative enzymes and highe
ionomycin or with anti-CD3 for 3 h. Subsequently, cells were lysed and RNA was isolate
are representative for three individual experiments. *P < 0.05 according to Student’s t-tes
10 lM ionomycin or with 30 lg/ml plate-bound anti-CD3 for 5 h. Expression levels of FH
Jurkat-IjBa cells (right panel) were pre-incubated with H2DCFDA for 10 min, followed
plate-bound anti-CD3 for 1 h. Then, ﬂuorescence of H2DCFDA was detected by FACS. (D
represents a biological triplicate.the anti-oxidative defence [7–9]. Therefore, we determined mRNA
expression levels of MnSOD and FHC by quantitative RT-PCR.
MnSODmRNA levels were upregulated by about two-fold in vector
control cells upon stimulation (Fig. 3A). However, Jurkat-IjBa cells
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as pronounced, was obtained for FHC. FHC expression was induced
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whether JNK is required for execution of apoptosis we targeted
JNK expression by siRNA. Treatment of Jurkat-IjBa cells withsiRNA siRNA
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JNK2 on the protein level after 48 h compared to control siRNA
treated cells (Fig. 4C). Downregulation of JNK resulted in signiﬁ-
cantly reduced apoptosis after stimulation (Fig. 4D).
3.5. Phosphatases are critically involved in apoptosis of Jurkat-IjBa
cells
We wanted to investigate the molecular mechanism for pro-
longed JNK phosphorylation. We assumed that upstream kinases,
such as MKK-4, are responsible for sustained JNK phosphorylation.
However, we observed that MKK-4 phosphorylation, though acti-
vated in Jurkat-IjBa cells, was not dependent on ROS as NAC had
no effect (Fig. 5A). Thus, we conclude that sustained JNK phosphor-
ylation is not mediated by upstream kinases.
The MAPK signaling cascades are also regulated by phospha-
tases. Phosphatases contain a critical cysteine residue in their cat-
alytical center which is susceptible to oxidation [17]. Oxidation of
the active site cysteine abrogates phosphatase function. To exam-
ine whether phosphatase activity might be affected by ROS in
Jurkat-IjBa cells, we applied a phosphatase activity assay. Phos-
phorylated JNK was incubated with cell extracts from stimulated
Jurkat-IjBa cells left untreated or co-treated with NAC. Treatment
of cells with PMA/ionomycin resulted in no or only minor phospha-
tase activity since phosphorylation of JNK was not altered up to
30 min of co-incubation with lysate (Fig. 5B, left panel). However,
addition of NAC restored phosphatase activity and, subsequently,
reduced JNK phosphorylation after 15–30 min of co-incubation
with lysate (Fig. 5B, right panel). Thus, sustained JNK phosphoryla-
tion is a result of ROS-mediated inactivation of phosphatases.
MKPs have rather non-redundant functions and show a high grade
of speciﬁcity for the members of the MAPK family [18]. MKP1,
MKP3, and MKP7 are expressed in T cells and were reported to
be strongly upregulated in leukocytes after activation [18,19].
MKP7 preferentially dephosphorylates JNK rather than ERK or
p38 [20,21], whereas MKP3 is speciﬁc for ERK dephosphorylation
[22,23]. MKP3 and MKP7 are localized in the cytosol and MKP1 is
localized in the nucleus [18]. This indicates a speciﬁc role of
MKP7 dephosphorylating JNK. Overexpression of MKPs was veri-
ﬁed by Western blot (Fig. 5C). Overexpression of MKP7 but not of
MKP1 and MKP3 blocked JNK phosphorylation (Fig. 5D). Next,
MKP overexpressing cells were stimulated and apoptosis was mea-
sured. Overexpression of MKP7 compared to other MKPs resulted
in the strongest decrease of apoptosis (Fig. 5E and F). This shows
that regulation of prolonged JNK activation by MKP7 is a crucial
step for survival and apoptosis induction in Jurkat T cells. Overex-
pression of MKP1 and MKP3 also lead to a partial block of apoptosis
(Fig. 5E and F), indicating that these phosphatases play a minor role
in apoptosis sensitization by inhibition of NF-jB. To further
strengthen the role of MKP7 in apoptosis regulation we speciﬁcally
targeted MKP7 expression by siRNA. Knock-down of MKP7 but not
of other MKPs resulted in a clear increase of apoptosis by CD3 or
PMA/Ionomycin stimulation (Fig. 5G). Therefore, these results
show the importance of MKP7 activity for apoptosis.
3.6. JNK induces BIM expression and BIM is important for apoptosis of
Jurkat-IjBa cells
How prolonged JNK activation causes apoptosis merits further
investigations. One putative mediator of CD95-independent apop-
tosis is BIM [24,25]. Further, it was shown that JNK can upregulate
the expression of BIM [26]. Indeed, we found that prolonged JNK
activation increased BIM expression whereas NAC blocked both,
JNK activation and BIM expression (Fig. 6A). NAC had no effect in
control Jurkat cells (data not shown). To further corroborate the
role of BIM we performed a speciﬁc knock-down of BIM by siRNA(Fig. 6B). Diminished expression of BIM did not interfere with
induction of apoptosis in Jurkat control cells (Fig. 6C and D) since
Jurkat cells undergo apoptosis upon stimulation in a CD95L-
dependent manner [27]. In contrast, apoptosis in Jurkat-IjBa cells
was strongly dependent on BIM expression (Fig. 6C and D). These
experiments show that JNK induces the expression of BIM an
important mediator for apoptosis in Jurkat-IjBa cells.4. Discussion
NF-jB is a crucial transcription factor involved in many physio-
logical processes including differentiation, proliferation, and cell
death. In this study, we describe the importance of NF-jB in T cells
for determination of the cellular fate and mode of apoptosis upon
TCR triggering. Activation of the TCR causes a plethora of signaling
events involving activation of kinases such as Lck, ZAP70, and PKCh
which ﬁnally culminate in the activation of transcription factors
NF-AT, NF-jB, and AP1 [28]. These and other transcription factors
induce expression of the CD95L that binds CD95. Triggering of the
CD95 receptor results in apoptosis [2]. Here we describe that in
TCR triggered T cells in which the NF-jB pathway is blocked apop-
tosis does not involve CD95 engagement. Our data indicate, that
apoptosis shows comparable hallmarks to TNFa-induced cell death
in NF-jB deﬁcient cells [8,9]. However, we could not observe a role
for TNFa since apoptosis was not impaired by soluble TNFa-
receptor Fc (Enbrel) (Supplementary Fig. 3). Here we show for
the ﬁrst time that a switch from classical AICD depending on the
CD95/CD95L to a CD95-independent apoptosis is observed. We
found that the inhibition of the NF-jB pathway impaired the
upregulation of anti-oxidative enzymes usually observed after
TCR stimulation (Fig. 3) [12]. Expression levels of MnSOD and
FHC were not increased by TCR triggering in Jurkat-IjBa cells in
which NF-jB activity is decreased. This led to a diminished anti-
oxidative capacity in these cells in comparison to vector control
cells with intact NF-jB activity. The diminished anti-oxidative
capacity was reﬂected by increased ROS production in Jurkat-IjBa
cells upon PMA or TCR stimulation (Fig. 3). In recent years, it has
become evident that ROS can act as a second messenger, modulat-
ing and regulating several signaling pathways [29]. Transcription
factors such as p53, Jun, Fos, and the p50 subunit of NF-jB can di-
rectly be oxidized altering their transcriptional activity [30]. The
most prominent targets of ROS, however, are phosphatases [29].
Oxidation abolishes phosphatase activity. In our study we observed
that MPK are inhibited in their function to dephosphorylate JNK in
Jurkat-IjBa cells. Decreased phosphatase activity could be rescued
by addition of NAC (Fig. 5). Further, we found that phosphatase
inactivation caused sustained JNK phosphorylation but not inhibi-
tion of upstream kinases such as MKK4. Recent studies shed more
light on subcellular localization of MKPs and possible dephospho-
rylation targets of these crucial regulators. Astonishingly, and in
contrast to other protein phosphatases, most MKPs show a high
grade of speciﬁcity for their targets. Substrate speciﬁcity assays
could prove that MKP7 has a strong preference for dephosphoryl-
ating JNK and p38 over ERK [20,21], whereas MKP3 rather acts
on ERK but not on JNK and p38 [22,23]. Both, MKP7 and MKP3,
were reported to be strongly upregulated in leukocytes after acti-
vation [19]. Another related phosphatase, MKP1, also acts on p38
and JNK. However, MKP1 is localized in the nucleus indicating that
it is not involved in cytoplasmic signaling [31–33]. This might ex-
plain why we detected that mainly MKP7 activity can inhibit apop-
tosis induced by TCR or PMA/ionomycin stimulation (Fig. 6). Our
experiments show for the ﬁrst time that MKPs are involved in reg-
ulation of TCR-triggered apoptosis. Inactivation of MKP7 by ROS,
and to a minor extent of other MKPs, resulted in sustained JNK acti-
vation. Further, speciﬁc knock-down of MKP7 induced
4688 M.K. Kießling et al. / FEBS Letters 584 (2010) 4679–4688spontaneous apoptosis but not in the case of MKP1 or MKP3 clearly
showing that MKP7 plays a prominent role in apoptosis regulation.
We also observed that caspases are involved in the above signaling
pathway (Fig. 1) which led to the assumption that caspases are act-
ing downstream of JNK phosphorylation. Other potential targets of
JNK are Bcl-2 family members. One study showed that JNK phos-
phorylates Bim, thus inducing Bax-dependent mitochondrial apop-
tosis [34]. We observed that knockdown of BIM had some inﬂuence
on apoptosis in vector cells (Fig. 6). However, the BIM knockdown
did strongly affect apoptosis in Jurkat-IjBa cells, thus, demonstrat-
ing that BIM is a downstream target of sustained JNK (Fig. 6).
Based on our results, we propose that inhibition of the NF-jB
pathway switches classical CD95-dependent AICD towards a mode
of apoptosis in which ROS-mediated MKP inactivation and subse-
quent sustained JNK activity are required.
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